Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05446805 · ClinicalTrials.gov registry record
Depression and Driving
A clinical trial of Depression and Drive, sponsored by Ganesh Babulal.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT05446805: Recruiting study of Depression and Drive, sponsored by Ganesh Babulal.
NCT05446805 is a study of Depression and Drive that is actively recruiting participants, run by Ganesh Babulal. The registered enrollment target is 150 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05446805, a study of Depression and Drive, is actively recruiting participants, sponsored by Ganesh Babulal.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will assess how depression, preclinical AD, and antidepressants affect driving behavior in cognitively normal older adults (65 years).
Primary Outcome
The latitude coordinate of the location of the vehicle being driven
Conditions Studied
Interventions
- DRUG F 18 AV-1451 (Flortaucipir)
- DRUG [11C]-Pittsburgh Compound B ([11C]PiB)
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-06-17 |
| Est. Completion | 2026-12-17 |
What NCT05446805 shows while recruiting
NCT05446805 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (81% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which F 18 AV-1451 (Flortaucipir) is the first listed.
NCT05446805 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05446805 about?
NCT05446805 is a clinical study titled "Depression and Driving". This project will assess how depression, preclinical AD, and antidepressants affect driving behavior in cognitively normal older adults (65 years).
What is the current status of trial NCT05446805?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2021-06-17. Estimated completion is 2026-12-17.
What conditions does trial NCT05446805 study?
This clinical trial studies the following conditions: Depression, Drive.
What interventions are being tested in trial NCT05446805?
The interventions under investigation include: F 18 AV-1451 (Flortaucipir) (DRUG), [11C]-Pittsburgh Compound B ([11C]PiB) (DRUG).
Who is sponsoring clinical trial NCT05446805?
This trial is sponsored by Ganesh Babulal, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05446805 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05446805's enrollment target sits among peer trials
150 249th of 679 higher than 416 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
-
Dopaminergic Therapy for Anhedonia - 2
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy